Positioning Statement
Latest News

BIO Ventures for Global Health

Impacting global health through multi-stakeholder initiatives, high impact partnering, and alliance management.

BVGH has a unique perspective: we look at the health problems facing developing countries and emerging markets through a dual lens with expertise in both global health and biopharmaceutical industry dynamics.

For more information about BVGH, services offered, or current programs download the brochure.


Merck & Co., Inc. publishes case study highlighting importance of collaboration in advancing healthcare in Africa

Merck & Co., Inc. recently published a case study highlighting fellowships BIO Ventures for Global Health (BVGH) organized and facilitated for two sets of Richard T. Clark fellows over the past two years. The fellows traveled to Africa where they worked with local universities to determine research interests, capabilities, needs and, ultimately, to identify BVGH program and partnership opportunities. Click here to read more. 

BVGH releases 2015 Partnership Hub Report summarizing WIPO Re:Search achievements

BIO Ventures for Global Health (BVGH) released the 2015 Partnership Hub Report today. The report summarizes partnering and communications objectives and achievements from the past year and highlights new members and member feedback. Click here to read more. 

BIO President and CEO Jim Greenwood to Chair BIO Ventures for Global Health Board of Directors

BIO Ventures for Global Health (BVGH) today announced that Jim Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO) has been elected as the new BVGH Board Chair for a term of three years. Click here to read more. 

Institut Pasteur joins WIPO Re:Search as 101st Member

WIPO Re:Search has now surpassed 100 members and is just shy of 100 agreements to share intellectual property in the fight against neglected tropical diseases, tuberculosis and malaria - both significant milestones for the consortium as it heads into its fifth full year of operation. Click here to read more. 

BVGH, Agilent Technologies, and Merck collaborate to build capacity in Africa to fight NTDs 

As a part of its Fellowship Program, BVGH sent a gently-used Agilent high-performance liquid chromatography (HPLC) system, alongside two Merck scientists, to the University of Buea in Cameroon. To read more about this instrument placement and fellowship, click here